| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels MK Madsen, PM Fisher, D Burmester, A Dyssegaard, DS Stenbæk, ... Neuropsychopharmacology 44 (7), 1328-1334, 2019 | 375 | 2019 |
| Beyond diagnostic accuracy: the clinical utility of diagnostic tests PMM Bossuyt, JB Reitsma, K Linnet, KGM Moons Clinical chemistry 58 (12), 1636-1643, 2012 | 356 | 2012 |
| Evaluation of regression procedures for methods comparison studies K Linnet Clinical chemistry 39 (3), 424-432, 1993 | 356 | 1993 |
| A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs K Linnet, TB Ejsing European Neuropsychopharmacology 18 (3), 157-169, 2008 | 213 | 2008 |
| Performance of Deming regression analysis in case of misspecified analytical error ratio in method comparison studies K Linnet Clinical chemistry 44 (5), 1024-1031, 1998 | 191 | 1998 |
| Contributions of five human cytochrome P450 isoforms to the N‐demethylation of clozapine in vitro at low and high concentrations OV Olesen, K Linnet The Journal of Clinical Pharmacology 41 (8), 823-832, 2001 | 185 | 2001 |
| Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC–TOF-MS MKK Nielsen, SS Johansen, PW Dalsgaard, K Linnet Forensic science international 196 (1-3), 85-92, 2010 | 183 | 2010 |
| Estimation of the linear relationship between the measurements of two methods with proportional errors K Linnet Statistics in medicine 9 (12), 1463-1473, 1990 | 176 | 1990 |
| Necessary sample size for method comparison studies based on regression analysis K Linnet Clinical chemistry 45 (6), 882-894, 1999 | 173 | 1999 |
| Quantifying the accuracy of a diagnostic test or marker K Linnet, PMM Bossuyt, KGM Moons, JB Reitsma Clinical chemistry 58 (9), 1292-1301, 2012 | 170 | 2012 |
| Quantifying the added value of a diagnostic test or marker KGM Moons, JAH de Groot, K Linnet, JB Reitsma, PMM Bossuyt Clinical chemistry 58 (10), 1408-1417, 2012 | 157 | 2012 |
| Metabolism of clozapine by cDNA-expressed human cytochrome P450 enzymes K Linnet, OV Olesen Drug metabolism and disposition 25 (12), 1379-1382, 1997 | 156 | 1997 |
| Protocols for determination of limits of detection and limits of quantitation; approved guideline DW Tholen, K Linnet, M Kondratovich, DA Armbruster, PE Garrett, ... CLSI EP17-A 24, 34, 2004 | 154 | 2004 |
| In vitro metabolism studies on mephedrone and analysis of forensic cases AJ Pedersen, LA Reitzel, SS Johansen, K Linnet Drug testing and analysis 5 (6), 430-438, 2013 | 150 | 2013 |
| Olanzapine serum concentrations in psychiatric patients given standard doses: the influence of comedication OV Olesen, K Linnet Therapeutic drug monitoring 21 (1), 87-90, 1999 | 150 | 1999 |
| Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS N Badawi, KW Simonsen, A Steentoft, IM Bernhoft, K Linnet Clinical Chemistry 55 (11), 2004-2018, 2009 | 147 | 2009 |
| Nonparametric estimation of reference intervals by simple and bootstrap-based procedures K Linnet Clinical chemistry 46 (6), 867-869, 2000 | 146 | 2000 |
| Serum concentrations and side effects in psychiatric patients during risperidone therapy OV Olesen, RW Licht, E Thomsen, T Bruun, JE Viftrup, K Linnet Therapeutic drug monitoring 20 (4), 380-384, 1998 | 140 | 1998 |
| Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes OV Olesen, K Linnet Pharmacology 59 (6), 298-309, 1999 | 135 | 1999 |
| Two-stage transformation systems for normalization of reference distributions evaluated. K Linnet Clinical chemistry 33 (3), 381-386, 1987 | 133 | 1987 |
